Amalgamated Bank Acquires 1,811 Shares of UiPath Inc. (NYSE:PATH)

Amalgamated Bank raised its stake in shares of UiPath Inc. (NYSE:PATH) by 7.1% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 27,312 shares of the healthcare company’s stock after acquiring an additional 1,811 shares during the period. Amalgamated Bank’s holdings in UiPath were worth $350,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Pacer Advisors Inc. bought a new position in UiPath during the second quarter valued at approximately $69,180,000. Vanguard Group Inc. raised its stake in UiPath by 5.6% during the 1st quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock valued at $911,741,000 after buying an additional 2,133,078 shares during the last quarter. Renaissance Technologies LLC bought a new position in shares of UiPath during the 2nd quarter valued at $13,280,000. AQR Capital Management LLC boosted its stake in shares of UiPath by 120.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,633,393 shares of the healthcare company’s stock worth $20,385,000 after buying an additional 892,845 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of UiPath by 37.2% in the second quarter. Dimensional Fund Advisors LP now owns 2,783,571 shares of the healthcare company’s stock worth $35,296,000 after acquiring an additional 754,519 shares during the period. Hedge funds and other institutional investors own 62.50% of the company’s stock.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. This trade represents a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 22.37% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on PATH shares. BMO Capital Markets raised their target price on UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a research report on Friday, September 6th. Royal Bank of Canada reissued a “sector perform” rating and issued a $16.00 price objective on shares of UiPath in a report on Friday, September 6th. TD Cowen cut their target price on shares of UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, September 6th. Morgan Stanley reiterated an “equal weight” rating and issued a $15.00 price target on shares of UiPath in a research report on Friday, September 6th. Finally, Wells Fargo & Company cut their price objective on shares of UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.47.

UiPath Trading Down 2.1 %

Shares of PATH opened at $12.37 on Monday. The business’s 50 day moving average is $12.61 and its 200 day moving average is $13.34. UiPath Inc. has a 12-month low of $10.37 and a 12-month high of $27.87. The company has a market capitalization of $6.80 billion, a PE ratio of -61.85 and a beta of 0.87.

UiPath (NYSE:PATH) last released its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.09) earnings per share. Equities research analysts predict that UiPath Inc. will post -0.23 earnings per share for the current year.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.